Engineers Gate Manager LP Ardelyx, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.05 - $9.74 $87,307 - $140,557	14,431 New	14,431 $105,000
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $34,663 - $62,928	-53,329 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $45,862 - $90,659	53,329 New	53,329 $59,000
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $126,269 - $159,183	-20,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $104,535 - $146,970	20,700 New	20,700 $134,000
Q3 2020 Nov 16, 2020	SELL	$5.25 - $7.08 $92,767 - $125,103	-17,670 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$5.37 - $8.11 $94,887 - $143,303	17,670 New	17,670 $122,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.